What is Emollivet?
Founded in 2019 and headquartered in Sweden, Emollivet operates at the intersection of biotechnology and veterinary care. The company specializes in the development of user-friendly, high-efficacy skin care products designed specifically for animals. By addressing the growing demand for sophisticated pet health management, Emollivet has carved out a distinct niche, moving beyond traditional grooming products into therapeutic-grade dermatological applications. Their market position is bolstered by a commitment to research-driven formulations that simplify the application process for pet owners and veterinary professionals alike, effectively bridging the gap between clinical efficacy and consumer convenience.
How much funding has Emollivet raised?
Emollivet has raised a total of $522K across 1 funding round:
Other Financing Round
$522K
Other Financing Round (2022): $522K with participation from Lipidor
Key Investors in Emollivet
Lipidor
Lipidor is a Swedish drug development company specializing in the formulation of topical products, leveraging proprietary technology to enhance the delivery of active ingredients.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Emollivet?
With the infusion of this latest capital, Emollivet is expected to transition from its foundational development phase into a period of aggressive commercial expansion. The strategic roadmap likely includes the scaling of manufacturing capabilities to meet international demand and the potential expansion of its product portfolio to address a broader spectrum of animal skin conditions. As the company leverages its recent financing, it will focus on strengthening its distribution channels across European markets and potentially exploring strategic partnerships to enhance its research and development pipeline. This phase of growth is critical for establishing Emollivet as a dominant player in the global animal health sector, ensuring that its innovative skin care technology reaches a wider demographic of veterinary clinics and retail consumers.
See full Emollivet company page
